Apolipoprotein E genotype does not influence the progression of multiple sclerosis

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Defining the clinical course of multiple sclerosis

1996 • 3,606 citations

Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?

1999 • 608 citations

Natural history of multiple sclerosis

1994 • 410 citations

Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis

2001 • 185 citations

APOE genotype is a major predictor of long-term progression of disability in MS

2001 • 176 citations

Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple Sclerosis

2002 • 129 citations

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility

2002 • 114 citations

Association of the APOE epsilon 4 allele with disease activity in multiple sclerosis

1999 • 102 citations

Multiple susceptibility loci for multiple sclerosis

2002 • 84 citations

Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians

1999 • 81 citations

A genome screen for multiple sclerosis in Italian families

2001 • 79 citations

Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease

1994 • 72 citations

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

2000 • 70 citations

APOE genotypes and disease severity in multiple sclerosis

2002 • 67 citations

Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis

2000 • 62 citations

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E)

2002 • 59 citations

APOE and risk of cognitive impairment in multiple sclerosis

2009 • 56 citations

The −491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism

1998 • 55 citations

APOE ε2-4 and -491 polymorphisms are not associated with MS

1999 • 45 citations

HLA-antigens and the prognosis of multiple sclerosis

1981 • 41 citations

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

2000 • 38 citations